1.Type 4 dual left anterior descending coronary artery.
Chan Joon KIM ; Hee Jeoung YOON ; Sung Ho HER ; Jun Han JEON ; Seung Min JUNG ; Eun Hee JANG ; Seung Won JIN
The Korean Journal of Internal Medicine 2015;30(5):727-729
No abstract available.
Aged
;
Angina Pectoris/diagnosis/etiology
;
Coronary Angiography
;
Coronary Artery Disease/*complications/diagnosis/therapy
;
Coronary Stenosis/*complications/diagnosis/therapy
;
Coronary Vessel Anomalies/*complications/diagnosis
;
Humans
;
Male
;
Percutaneous Coronary Intervention/instrumentation
;
Stents
;
Treatment Outcome
2.Impact of depression on prognosis of patients with coronary heart disease undergoing revascularization.
Xi-ming LI ; Ting-ting LI ; Hong-liang CONG ; Zhi-gang GUO ; Jing-hua SONG ; Ru ZHAO ; Jian-yong XIAO
Chinese Journal of Cardiology 2012;40(2):99-103
OBJECTIVETo investigate the impact of depression on clinical outcome of patients undergoing revascularization.
METHODSSelf-rating depression scale (SDS) assessment was made before and after coronary artery bypass grafting (CABG, n = 345) and percutaneous coronary intervention (PCI, n = 308) procedure. Patients were divided into depression and non-depression group. All patients were followed up for 12 months after procedure for the occurrence of rehospitalization and major adverse cardiovascular events (MACE) including all-cause mortality, nonfatal myocardial infarction or target lesion revascularization.
RESULTSDepression was present in 40.9% (n = 141) of patients after CABG, which was significantly higher than before procedure (24.3%, P < 0.01). The MACE rate was significantly higher in patients with post-procedure depression [8.5% (12/141)] than in patients without depression [2.9% (6/204), P < 0.05] and the incidences of target lesion revascularization and rehospitalization were also significantly higher in depression patients than in non-depression patients during the 12 months follow-up (all P < 0.05). Depression was present in 36.4% (n = 112) of patients after PCI, which was significantly higher than that before procedure (28.6%, P < 0.05). The MACE rate [8.0% (9/112) vs. 2.0% (4/196)] and rehospitalization rate [12.5% (14/112) vs. 4.6% (9/196)] were significantly higher in depression patients than in patients without depression during the 12 months follow-up (P < 0.05). There was no significant difference on SDS score between the PCI and CABG before the procedure. However, after the procedure, the SDS score for patients undergoing CABG was significantly higher than in patients undergoing PCI (48.9 ± 9.8 vs. 45.7 ± 10.5 P = 0.01). The level of serum IL-6 was significantly higher in depression patients than in patients without depression (P < 0.05).
CONCLUSIONPrevalence of depression is high in patients treated with revascularization procedures and is linked with poor post-procedure prognosis.
Aged ; Angioplasty, Balloon, Coronary ; Coronary Artery Bypass ; Coronary Disease ; diagnosis ; psychology ; therapy ; Coronary Stenosis ; Depression ; etiology ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Treatment Outcome
3.Percutaneous Transluminal Coronary Angioplasty for Coronary Artery Stenosis in a Young Patient with Long Term Kawasaki Disease.
Seok In HONG ; Pum Joon KIM ; Ki Bae SEUNG ; Jung Hyun KWON ; Ju Yeal BEAK ; Chang Dong YEO ; Kyu Bo CHOI
The Korean Journal of Internal Medicine 2005;20(2):187-190
Kawasaki Disease (KD) is an acute, febrile, multisystem disease of children. More severe complications in 15~25% of cases include, the development of coronary aneurysms, ischemic heart disease, and sudden cardiac death. The standard treatment for significant coronary artery stenosis has generally been aortocoronary bypass surgery, although percutaneous transluminal coronary angioplasty (PTCA) has been described in a small number of patients. This report describes a 14 year old boy with a history of KD who developed multiple coronary aneurysms and stenosis. We performed PTCA, which was successful in relieving the stenosis of the left circumflex artery.
Adolescent
;
*Angioplasty, Transluminal, Percutaneous Coronary
;
Coronary Aneurysm/diagnosis/etiology/therapy
;
Coronary Angiography
;
Coronary Stenosis/diagnosis/etiology/*therapy
;
Coronary Vessels/ultrasonography
;
Endosonography
;
Follow-Up Studies
;
Humans
;
Male
;
Mucocutaneous Lymph Node Syndrome/*complications/diagnosis
4.Diabetes mellitus and heart disease.
Anand AMBHORE ; Swee Guan TEO ; Kian Keong POH
Singapore medical journal 2013;54(7):370-quiz 376
Diabetes mellitus is responsible for diverse cardiovascular complications such as accelerated atherosclerosis, increased plaque burden and diffuse coronary lesions. It is also a major risk factor for myocardial infarction, stroke and peripheral vascular disease. Here, we present two cases. The first patient had subtle changes in the ECGs, with severe coronary artery disease requiring coronary artery bypass grafting, while the second had deep T wave inversion in the ECG and was found to have normal coronary arteries and nonischaemic cardiomyopathy. Although ECG failed to show the severity of the disease, it is invaluable as a simple, noninvasive test to aid in diagnosis. Our two cases stress the importance of a high index of suspicion and the low threshold for investigations in the diabetic population.
Aged
;
Biomarkers
;
analysis
;
Combined Modality Therapy
;
Coronary Angiography
;
Coronary Artery Bypass
;
Coronary Stenosis
;
diagnosis
;
therapy
;
Diabetes Complications
;
diagnosis
;
drug therapy
;
surgery
;
Diagnosis, Differential
;
Electrocardiography
;
Humans
;
Male
;
Middle Aged
;
Pulmonary Edema
;
diagnosis
;
therapy
;
Radiography, Thoracic
5.The Diagnostic Values of 99mTc-HexaMIBI Myocardial SPECT in Acute Myocardial Infarction.
Se Hwan HAN ; Tae Jun KIM ; Hyo Seok KIM ; Dong Jib RA ; Jin Kyung KIM ; Jin Kook KIM ; Sung Koo KIM ; Young Joo KWON
Korean Circulation Journal 1994;24(3):426-432
BACKGROUND: Thalium 201(TI-201) has been a widely applied myocardial perfusion agent for the detection of coronary artery disease. however its low emission energy and long half-life make this agent suboptiomal for the examination of coronary artery disease. To circumvent the physical limitation of TI-201, a group of technetium 99m-labeled isonitril complex has been developed. Our study was done to examine the value of SPECT with 99mTc-HexaMIBI in estimating myocardial perfusion in patients with myocardial infarction. METHODS: We evaluated the sensitivity of SPECT with 99mTc-HexaMIBI in 29 patients with acute myocardial infarction. We also compared the severity and vascular territory of abnormal perfusion on SPECT scanning with severity of coronary artery stenosis, values of serum enzyme and sites in ECG. RESULTS: 1) There were 26 patients(90%) who showed perfusion defect, and 3 patients(10%) who showed normal perfusion in myocardial SPECT. The 3 patients with normal perfusion demonstrated non Q-wave infarction of ECG. 2) Among 23 patients performed coronary argiography, there were 19 patients(82%) who showed positive findings on myocardial SPECT and luminal narrowing above 50% on coronary angiogram, and there were 3 patients(13%) who showed significant coronary artery stenosis in spite of negative myocardial SPECT. 3) The grade of perfusion defect showed no significant difference between groups undergone thrombolytic therapy and groups not undergone thrombolytic therapy. 4) There was good correlation between the site of perfusion defect on SPECT and the site of infarction on ECG. CONCLUSION: We conclude that SPECT with 99mTc-HexaMIBI is a promising non invasive test for simultaneous diagnosis of myocardial infarction and evaluation of perfusion defect.
Coronary Artery Disease
;
Coronary Stenosis
;
Diagnosis
;
Electrocardiography
;
Half-Life
;
Humans
;
Infarction
;
Myocardial Infarction*
;
Perfusion
;
Phenobarbital
;
Technetium
;
Technetium Tc 99m Sestamibi*
;
Thrombolytic Therapy
;
Tomography, Emission-Computed, Single-Photon*
6.Serial Morphological Changes of Side-Branch Ostium after Paclitaxel-Coated Balloon Treatment of De Novo Coronary Lesions of Main Vessels.
Ae Young HER ; Soe Hee ANN ; Gillian Balbir SINGH ; Yong Hoon KIM ; Takayuki OKAMURA ; Scot GARG ; Bon Kwon KOO ; Eun Seok SHIN
Yonsei Medical Journal 2016;57(3):606-613
PURPOSE: The effects on the side-branch (SB) ostium, following paclitaxel-coated balloon (PCB) treatment of de novo coronary lesions of main vessels have not been previously investigated. This study was aimed at evaluating the serial morphological changes of the SB ostium after PCB treatment of de novo coronary lesions of main vessels using optical coherence tomography (OCT). MATERIALS AND METHODS: This prospective, single-center observational study enrolled patients with de novo lesions, which were traversed by at least one SB (≥1.5 mm) and were treated with PCB. The SB ostium was evaluated with serial angiographic and OCT assessments pre- and post-procedure, and at 9-months follow-up. RESULTS: Sixteen main vessel lesions were successfully treated with PCB, and 26 SBs were included for analysis. Mean SB ostial lumen area increased at 9-months follow-up (0.92±0.68 mm2 pre-procedure, 1.03±0.77 mm2 post-procedure and 1.42±1.18 mm2 at 9-months). The SB ostial lumen area gain was 0.02±0.24 mm2 between pre- and post-procedure, 0.37±0.64 mm2 between post-procedure and 9-months, and 0.60±0.93 mm2 between pre-procedure and 9-months. The ostial lumen area increased by 3.9% [interquartile range (IQR) of -33.3 to 10.4%] between pre- and post-procedure, 52.1% (IQR of -0.7 to 77.3%) between post-procedure and 9-months and 76.1% (IQR of 18.2 to 86.6%) between pre-procedure and 9-months. CONCLUSION: PCB treatment of de novo coronary lesions of main vessels resulted in an increase in the SB ostial lumen area at 9-months.
Aged
;
Angioplasty, Balloon, Coronary/*methods
;
Coronary Angiography
;
Coronary Stenosis/diagnosis/*therapy
;
Coronary Vessels/*pathology
;
*Drug-Eluting Stents/adverse effects
;
Female
;
Humans
;
Male
;
Middle Aged
;
Paclitaxel/*administration & dosage
;
Prospective Studies
;
Tomography, Optical Coherence/*methods
;
Treatment Outcome
;
Tubulin Modulators/administration & dosage
7.Funtional significance of the intermediate lesion in a single coronary artery assessed by fractional flow reserve.
Sang Jin HA ; Se Hwan KWON ; Soo Joong KIM
The Korean Journal of Internal Medicine 2014;29(6):822-824
No abstract available.
Cardiac Catheterization
;
Cardiovascular Agents/therapeutic use
;
Collateral Circulation
;
Coronary Angiography/methods
;
Coronary Stenosis/*diagnosis/drug therapy/physiopathology
;
Coronary Vessel Anomalies/*diagnosis/physiopathology
;
*Fractional Flow Reserve, Myocardial
;
Humans
;
Male
;
Middle Aged
;
Severity of Illness Index
;
Tomography, X-Ray Computed
8.Two dislodged and crushed coronary stents: treatment of two simultaneously dislodged stents using crushing techniques.
Dong Hyeok YANG ; Seong Ill WOO ; Dae Hyeok KIM ; Sang Don PARK ; Ji Hun JANG ; Jun KWAN ; Sung Hee SHIN
The Korean Journal of Internal Medicine 2013;28(6):718-723
Coronary stent dislodgement is a rare complication of percutaneous coronary intervention. We report a rare case of dislodgement of two intracoronary stents. On withdrawal of two balloon catheters, one with a guide wire was mechanically distorted from the left main (LM) to the proximal left anterior descending artery (LAD) while the other was dislodged from the LM to the ostial left circumflex artery. The stent in the LAD could not be retrieved into the guide catheter using a Goose neck snare, because it was caught on a previously deployed stent at the mid LAD. A new stent was quickly deployed from the LM to the proximal LAD, because the patient developed cardiogenic shock. Both stents, including a distorted and elongated stent, were crushed to the LM wall. Stent deployment and crushing may be a good alternative technique to retrieving a dislodged stent.
Angioplasty, Balloon, Coronary/adverse effects/*instrumentation
;
Cardiac Catheterization/adverse effects/*instrumentation
;
Coronary Angiography
;
Coronary Stenosis/diagnosis/*therapy
;
Female
;
Humans
;
Middle Aged
;
Prosthesis Failure
;
Shock, Cardiogenic/etiology/therapy
;
*Stents
;
Treatment Outcome
9.Prediction of Coronary Atherosclerotic Ostial Lesion with a Damping of the Pressure Tracing during Diagnostic Coronary Angiography.
Ae Young HER ; Soe Hee ANN ; Gillian Balbir SINGH ; Yong Hoon KIM ; Bon Kwon KOO ; Eun Seok SHIN
Yonsei Medical Journal 2016;57(1):58-63
PURPOSE: When performing coronary angiography (CAG), diagnostic catheter intubation to the ostium can cause damping of the pressure tracing. The aim of this study was to determine the predictors of atherosclerotic ostial stenosis in patients showing pressure damping during CAG. MATERIALS AND METHODS: In total, 2926 patients who underwent diagnostic CAG were screened in this study. Pressure damping was defined as an abrupt decline of the coronary blood pressure with a blunted pulse pressure after engagement of the diagnostic catheter. According to CAG and intravascular ultrasound (IVUS), we divided damped ostia into two groups: atherosclerotic ostial lesion group (true lesion group) and non-atherosclerotic ostium group (false lesion group). Clinical and angiographic characteristics were compared between the two groups. RESULTS: The overall incidence of pressure damping was 2.3% (68 patients and 76 ostia). Among the pressure damped ostia, 40.8% (31 of 76 ostia) were true atherosclerotic ostial lesions (true lesion group). The true lesion group had more frequent left main ostial damping and more percutaneous coronary interventions (PCIs) performed on non-ostial lesions, compared to the false lesion group. On multivariate logistic regression analysis, left main ostial damping [hazard ratio (HR) 4.11, 95% confidence interval (CI) 1.24-13.67, p=0.021] and PCI on non-ostial lesion (HR 5.34, 95% CI 1.34-21.27, p=0.018) emerged as independent predictors for true atherosclerotic ostial lesions in patients with pressure damping. CONCLUSION: Left main ostial damping and the presence of a non-ostial atherosclerotic lesion may suggest a significant true atherosclerotic lesion in the coronary ostium.
Aged
;
*Coronary Angiography
;
Coronary Artery Disease/etiology/*radiography
;
Coronary Occlusion/diagnosis/*therapy
;
Coronary Stenosis/etiology/*radiography
;
Coronary Vessel Anomalies/radiography
;
Coronary Vessels/*pathology
;
Female
;
Humans
;
Incidence
;
Male
;
Middle Aged
;
Percutaneous Coronary Intervention/adverse effects/methods
;
Predictive Value of Tests
;
Proportional Hazards Models
;
Radiography, Interventional
10.Long-term Outcomes of Medical Therapy Versus Coronary Revascularisation in Patients with Intermediate Stenoses Guided by Pressure Wire.
Hongyu SHI ; Chi Hang LEE ; Mark Y Y CHAN ; Adrian F LOW ; Swee Guan TEO ; Koo Hui CHAN ; Rishi SETHI ; Arthur Mark RICHARDS ; Huay Cheem TAN
Annals of the Academy of Medicine, Singapore 2015;44(5):157-163
INTRODUCTIONThis study aimed to examine the long-term clinical outcomes of coronary fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) in a real-world population in an Asian tertiary centre.
MATERIALS AND METHODSAll patients who underwent FFR measurement for intermediate coronary lesions in our centre from June 2002 to December 2009 were enrolled. A threshold of FFR ≤0.75 was used for revascularisation. All the patients were prospectively followed-up for major adverse cardiac events (MACE) of death, myocardial infarction (MI), target vessel revascularisation (TVR) and stent thrombosis.
RESULTSBased on FFR measurement, 368 (57%) patients were treated medically while 278 (43%) underwent revascularisation. At a mean follow-up duration of 29.7 ± 16 months, 53 (14.4%) patients in the medical therapy group and 32 (11.5%) patients in the revascularised group experienced MACE (P = 0.282). There were no statistical differences in all the clinical endpoints between the 2 groups.
CONCLUSIONMedical therapy based on FFR measurement is associated with low incidences of MACE at long-term follow-up.
Adult ; Aged ; Aspirin ; therapeutic use ; Coronary Stenosis ; complications ; diagnosis ; therapy ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Percutaneous Coronary Intervention ; methods ; Platelet Aggregation Inhibitors ; therapeutic use ; Retrospective Studies ; Ticlopidine ; analogs & derivatives ; therapeutic use ; Treatment Outcome